La Jolla Pharmaceutical Co
LJPCDelisted Aug 22, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000920465
La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.
Holders of 5% or more of LJPC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of La Jolla Pharmaceutical Co, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of La Jolla Pharmaceutical Co on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on La Jolla Pharmaceutical Co, newest first.
No Schedule 13D or 13G filings on La Jolla Pharmaceutical Co are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell La Jolla Pharmaceutical Co shares.
No Form 144 notices for La Jolla Pharmaceutical Co are on file.